Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Primary Treatment of Light Chain Amyloidosis with Bortezomib, Lenalidomide, and Dexamethasone (VRD): Effective Regimen Inducing Response w/in 3 mths, Toxicity Manageable

19 views
November 18, 2019
0 Comments
Login to view comments. Click here to Login